Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Heather Bresch
Payers
Senators call on Mylan to return DoD overpayments
A trio of senators is now asking Mylan to return at least $50 million in overpayments for EpiPens made by the Department of Defense.
Evan Sweeney
Nov 8, 2016 2:42pm
Mylan settlement leaves execs unscathed
Oct 28, 2016 11:29am
Mylan, DOJ agree to $465M settlement over EpiPen misclassification
Oct 12, 2016 8:46am
How drug coupons 'undermine' payers' efforts to trim costs
Oct 11, 2016 12:26pm
Pharma execs shift blame to PBMs for rising drug costs
Oct 3, 2016 10:50am
Part D spending on EpiPens jumped more than 1,100% in 7 years
Sep 21, 2016 11:50am
